Rodríguez-Gil, A.; Carrillo-Cruz, E.; Marrero-Cepeda, C.; Rodríguez, G.; Pérez-Simón, J.A. Effect of Vitamin D on Graft-Versus-Host Disease. Biomedicines2022, 10, 987.
Rodríguez-Gil, A.; Carrillo-Cruz, E.; Marrero-Cepeda, C.; Rodríguez, G.; Pérez-Simón, J.A. Effect of Vitamin D on Graft-Versus-Host Disease. Biomedicines 2022, 10, 987.
Cite as:
Rodríguez-Gil, A.; Carrillo-Cruz, E.; Marrero-Cepeda, C.; Rodríguez, G.; Pérez-Simón, J.A. Effect of Vitamin D on Graft-Versus-Host Disease. Biomedicines2022, 10, 987.
Rodríguez-Gil, A.; Carrillo-Cruz, E.; Marrero-Cepeda, C.; Rodríguez, G.; Pérez-Simón, J.A. Effect of Vitamin D on Graft-Versus-Host Disease. Biomedicines 2022, 10, 987.
Abstract
The different cell subsets of the immune system express vitamin D receptor (VDR). Through VDR, vitamin D exerts different functions which influences on immune responses, as previously shown in different preclinical models. Based on this background, retrospective studies have explored the impact of vitamin D levels on the outcome of patients undergoing allogeneic hematopoietic stem cell transplantation, showing that vitamin D deficiency is related to an increased risk of complications, especially graft-versus-host disease. These results have been confirmed in a prospective cohorts trial, although further studies are required to confirm this data. In addition, the role of vitamin D on the treatment of hematologic malignancies has also been explored. Considering this dual effect both on the immune system as well as on tumor cells in patients with hematologic malignancies, vitamin D might be useful in this setting both to decrease graft-versus-host disease and relapse rates.
Keywords
vitamin D; calcifediol; cailcitriol; graft-versus-host disease; vitamin D receptor (VDR)
Subject
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.